Stay updated on Elotuzumab in Myeloma: VRD Induction Clinical Trial
Sign up to get notified when there's something new on the Elotuzumab in Myeloma: VRD Induction Clinical Trial page.

Latest updates to the Elotuzumab in Myeloma: VRD Induction Clinical Trial page
- ChecktodayChange DetectedA banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.7%

- Check7 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check14 days agoChange DetectedThe footer now identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check35 days agoChange DetectedA new revision v3.7.0 is added to the record history, replacing the previous v3.6.6 entry.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry, Revision: v3.6.6, is added to the study record history and the previous Revision: v3.6.5 entry is removed, indicating an update to the record's submission history.SummaryDifference0.1%

- Check77 days agoChange DetectedA new entry 'Revision: v3.6.5' was added to the Record History. The previous 'Revision: v3.6.4' entry was removed, reflecting an update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to Elotuzumab in Myeloma: VRD Induction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elotuzumab in Myeloma: VRD Induction Clinical Trial page.